How precision health is transforming care coordination strategies: Q&A with hc1’s Brad Bostic

Here, Brad Bostic, CEO of hc1, discusses how precision health is changing healthcare today, from medication delivery to laboratory testing and COVID-19.

Editors note: Responses have been gently modified for clearness and length.

The shift to using data analytics and remote monitoring technologies to much better track clients health gradually is becoming a brand-new way to curb costs because it enables providers to capture clients conditions and illness prior to they escalate.

In collaboration with hc1 –
Monday, October 26th, 2020

Faced with intensifying costs of care and administrative requirements that eliminate from their patient face time, suppliers are turning to precision health innovations to embrace more proactive and customized care strategies.

Question: What do you see as the essential obstacles we are facing today in health care?

Brad Bostic: We have an incredibly stressed out, really finite base of caretakers in health care today who want to do their finest job in general to look after clients, however there simply arent sufficient hours in the day. When you layer on the needs that come with all the more current data entry requirements, this is specifically true. I understand a lot of folks that practice health care seem like they invest half their time interfacing with a computer system instead of with clients, so that pressure on the time that is readily available in a day is significant. Combined with that, weve had some significant escalation in costs in health care.

The scarcity of time and the pressure on expenses together create a quite challenging situation and ultimately thats where we need to be focused. Moving forward on healthcare internationally is how we can allow the extremely valuable individuals who exist to provide care and interface with patients with the insight they require to provide that care actually exactly and effectively. When you take a look at how siloed the data is, it compounds this difficulty. If you have an offered person who sees numerous various physicians for persistent conditions and theyre on lots of different medications, theyre being checked in various different locations with lab and other diagnostic methods. The service provider ends with an even larger problem from a time management and care shipment perspective because not just do you not have enough time already as a caregiver, however now youre dealing with really insufficient info and attempting to combine all the information from all these different siloes is almost impossible. Even if it might be done it would take a lot handbook effort, so it just does not take place very frequently.

Q: How is precision health changing care delivery?

20 percent of individuals will fail their cholesterol medication due to the fact that they have a special genetic mutation that makes it so they cant metabolize the medication or theyre an ultra quick metabolizer. We prescribe to people in a manner that assumes everybody is exactly the exact same. You have these kinds of problems where across the board individuals are not getting better due to the fact that theyre being treated with a blunt instrument method versus an exact instrument method.

Precision health is changing care shipment across numerous different facets varying all the method from the old trend toward the quantified self where youre determining and monitoring activities through a biometric watch band or a smartwatch to construct a far more accurate view of you; thats at the customer level. Moving more into the care shipment world, accuracy health has actually had a huge effect on oncology for the much better. We have gotten much smarter at analyzing all the way down to the distinct genetic anomalies to identify who can take advantage of what treatment most effectively. Approximately about 5 percent or less of the patients in an offered health system are oncology related, so there is this other 95 percent of clients who are not necessarily taking advantage of precision health and truly must have that opportunity. What we see taking place here is this enlightenment taking place throughout the board with caregivers, and health insurance for that matter, where theyre recognizing that if you can start zeroing in on how to optimally identify individuals sooner by using the most innovative diagnostic tests with an emphasis on lab testing, theres also an opportunity then to tailor the medication therapy for that person in a holistic way so youre not overprescribing them with lots of different physicians that are contravening each other. Youre not causing damage with the medications that are being prescribed, and youre ensuring that those medications are going to work all the way down to the genetic level. That gives you the opportunity to deliver mass precision health versus the really finite mate concentrated on oncology.

Q: How is precision health changing behavioral health care shipment?

BB: A great deal of the psychological and behavioral health screening for medications has gotten more accurate, but using genomic information, and in this case with an emphasis on optimized recommending through pharmacogenetic screening, is a huge chance to advance accuracy health for the huge base of otherwise underserved or disregarded clients who could be hurt or might be failing their medication. You can likewise actually zero in on how you efficiently identify by ensuring that every patient gets the right test as quickly as possible. There are about 40 percent of patients who dont receive all of the screening that they should get, therefore theres an under utilization of the diagnostic tools that are available to the laboratory. Powering up every supplier to the highest possible level of insight on exactly what the medical diagnosis is based on doing the right screening and precisely what the best prescription is all the method down to your special genetic anomalies, eliminating the conflicting medications and constantly tracking that patients are staying on the medications that are going to work best for them. Those are the manner ins which we see this precision screening and prescribing one-two punch that we see accuracy health ending up being a more widespread mass market application or mass personalization, which is developing on a great deal of success that has been seen in smaller sized mates like oncology however spreading out that accuracy health worth throughout the whole area of all patients.

BB: First of all, you have actually to have actually advanced analytics that zero-in based on a large selection of data points brought together in a typical client profile that can identify who those individuals are that have the highest danger for having issues with their health. When those individuals are recognized, engage them in a method to laboratory testing that isnt just the one-size-fits-all experimental model of saying: Well simply run this panel or that panel, but in fact having a very exact approach to the testing that youre going to run on every single person who does fall into these greater danger categories. Thats a specific example where if you have the analytical insights and the triggers that can notify these caregivers of people who have these otherwise silent threat factors, you can engage proactively and create a substantial boost in health and well being while simultaneously dramatically lowering the cost of health care.

Q: What must occur today in order for accuracy health to get medical diagnosis closer to the start of illness when it matters most so treatment and treatments can be even more reliable for patients?

Q: From your perspective, how are health system leaders stabilizing the transition from fee-for-service practices while introducing value-based ones?

Q: What effect are COVID-19 and the upcoming election possibly having on healthcare in the United States from your viewpoint working with labs and health systems?

Most of laboratories clearly have actually moved the bulk of their focus toward providing screening capacity for COVID-19. Theyve needed to retool their instruments and get access to the reagents and products they need to do that testing, whichs been an extremely unpleasant process that has exposed that, from a supply chain perspective, we really didnt have the slack to be able to ramp up as quickly as we would like. Theres definitely a great deal of innovation going on related to detecting the presence of the virus and likewise the presence of the antibodies for people who have been just recently exposed and they no longer have the infection present. Downstream though the antibodies in fact tend to wane in regards to their existence in the system, so its actually a T cell associated reaction that would keep you protected from extreme consequences due to infection. I believe there will be some testing capabilities developed that will go all the method to that level to understand, OK, this person although theyre disappointing antibodies, their body has a T cell response that suggests theyve had the virus and it knows how to protect itself from reinfection or a minimum of keep it to a minimum..

BB: If we separate the political from more of the practical … from an useful point of view, the COVID-19 pandemic has certainly improved the healthcare market and it will permanently be changed. Theres a realization now that a great deal of the cutting of investment into certain testing capability in the name of efficiency has developed vulnerability. Moving on, I believe well see that were more apt to be supporting investment in laboratory and health systems that would be ready to respond if theres a pathogen that presents itself like the SARS-CoV-2 infection has actually emerged.

I d say on the treatment side, much like polio where individuals were exposed to that infection and there was no vaccine and they might get much better but they d end up with long-term issues like the loss of strength in a given extremity that lasts for life. I think we have the very same potential concerns like how polio caused however that relate to respiratory, lung and all these other concerns that were finding out about and beginning to study, I believe that COVID-19 alters the game due to the fact that were going to need to be much more effective at this continuous tracking and management of the people who have been contaminated.

From our viewpoint, these leaders and people who are moving into more of the value-based paradigm are incredibly excellent at performing on efforts that make health care expenses less not by stripping out services that clients need but by including smart delivery systems that permit them to personalize care and ultimately make people healthier. If youre carrying out on an accuracy testing and recommending program that makes sure that all of the hundreds of thousands of individuals that are under a value-based health plan arrangement are getting on the ideal medications that are constantly kept an eye on for prospective health problems utilizing effective diagnostic testing, you end up with this much healthier population that costs a lot less.

A great example of where you can do this is with respect to the widespread misprespcribing issue that happens within health systems. We do analyses on significant populations of hundreds of thousands of individuals, and we regularly discover that more than 20 percent of the individuals who are on multiple medications are on medications that conflict with each other, that are harmful to that patient or might in fact not even work for the patient based on their genetic mutations. In the U.S., more than 120,000 deaths per year occur from individuals taking medications as recommended; we have hundreds of thousands of individuals who are dying every year because theyre taking medications as recommended.

With that stated, we also see some outstanding health systems that we work with throughout the nation who have really come together and brought the health strategy and the care delivery management together to say, What can we do to meaningfully reduce the expense of delivering care, while at the same time enhancing outcomes? We see some health systems that truly lean in and establish a clear value-based contracting lorry with their health plan. In some cases, these health plans are owned wholly or in part by the actual health system.

Q: How will COVID-19 potentially affect treatment therapies and medication advancement?

BB: We are going to begin to get a lot smarter; we currently are getting a lot smarter about what medication treatments work for individuals who have been exposed and who have actually contracted the COVID-19 infection. Eventually we have years and years of research study in antiviral medications, which was mainly produced by the HIV virus. Because we have a lot of anti viral capability, this gives us a huge advantage now today. Because of advancements in upfront diagnosing capabilities by means of extremely sensitive and specific screening, we will be much better prepared for responding and noticing to prospective pandemics. When radar was very first developed; it was this new capability to see possibly hours in advance that youve got a threat coming in a war, its like. Though, people didnt actually trust it and so they would just disregard it and then they get bombed to smithereens even though they saw a couple hours ahead of time that there were bombers coming in. I believe we then said, Well, this radar thing is no joke. We require the same thing with COVID-19 and with other possible pathogens where you start seeing these things reveal up in different pockets of the world. We require an automated way to be cautioned and be able to sense and respond and begin driving the things that you can do to consist of these pathogens, rather than letting them spread and then remaining in this years-long mitigation effort that has actually obviously developed a great deal of discomfort.

COVID-19 will alter the face of health care and how we manage health in the U.S. in a way that is analogous to how 9/11 changed the way we manage security with travel. Its been 20 years because 9/11, and we are still going through the exact same kind of security process at the airports and looking into peoples danger aspects. We came up with TSA pre-check, which eventually provided a more streamlined method for people who were looking to travel and had the kind of qualifications or attributes that would make them low risk.

Q: How has the new category of Precision Health Insight Networks (PHIN) contributed throughout this pandemic to support healthcare experts?

If youre carrying out on an accuracy testing and prescribing program that makes sure that all of the hundreds of thousands of individuals that are under a value-based health plan arrangement are getting on the optimal medications that are continually monitored for prospective health issues utilizing effective diagnostic screening, you end up with this much healthier population that costs a lot less. All of these things can be made possible in a much more organized method through Precision Health Insight Networks, because unlike the sort of standard approach to health technology, which is extremely much and very siloed focused on attempting to automate things inside an offered health system or healthcare facility, Precision Health Insight networks bring things together at scale throughout the whole nation so you can deliver on the important insight, analytics and options required to sense and react to dangers and then drive action in order to make people healthier and much safer.

Approximately about 5 percent or less of the clients in a provided health system are oncology related, so there is this other 95 percent of patients who are not always benefitting from accuracy health and really should have that chance. BB: A lot of the psychological and behavioral health testing for medications has gotten more exact, however using genomic info, and in this case with a focus on optimized recommending through pharmacogenetic testing, is a substantial opportunity to advance precision health for the huge base of otherwise underserved or disregarded clients who could be damaged or could be failing their medication. Those are the ways that we see this precision testing and prescribing one-two punch that we see precision health becoming a more prevalent mass market application or mass customization, which is constructing on a lot of success that has actually been seen in smaller cohorts like oncology but spreading out that precision health value across the whole stretch of all clients.

BB: There has been a substantial financial investment by all federal government, specific health systems and even health prepares into these EHR systems and other data management systems that are developed to make it more possible to document the activities that happen in health care throughout a patient journey, encounter or series of encounters. Those systems, while they made information digital that maybe existed before in paper, they really have not done anything to resolve for the more comprehensive absence of connection among various islands of information that continues to pervade U.S. healthcare. Now you simply have a whole bunch of different organizations that have invested numerous millions, or billions, of dollars to put in location these databases that are below their EHRs that still dont really share a common view and they dont really get a longitudinal representation across several various places on whats happening with populations or with individual patients..

More articles on health IT: FDA holds public meeting on AI, concentrates on information training biasCyberattacks are closing down hospital IT networks: 8 current incidentsAmazon health care leader departs for equity capital firm.

Precision Health Insight Networks have actually caused this brand-new period of insight that can be gleaned from information when theres a safe and secure cloud overlay of connectivity that brings together all of the key data points that can, in a scalable way, be united to generate an awareness of where theres risk and then drive action to go address that danger. Specific to the pandemic, theres the hc1 national Precision Health Insight Network capability thats connected to more than 22,000 laboratory screening locations and has the ability to unite this enormous amount of insight in real time thats covering roughly half of all of the screening for COVID-19 in the U.S. And were speaking about not a week or month later, were speaking about actually actual time dishing out as results are created what the threat remains in an offered micro neighborhood down all the method to a population clusters of about 100,000 people throughout the entire U.S.– you can see what the presence is of the virus and whether its accelerating or slowing down and then eventually utilize that to notify decisions like safe back-to-work programs or safe travel or being able to safely attend a sporting event or go back to your university. All of these things can be made possible in a much more methodical way through Precision Health Insight Networks, due to the fact that unlike the sort of conventional method to health innovation, which is very much and very siloed focused on trying to automate things inside an offered health system or health center, Precision Health Insight networks bring things together at scale throughout the entire country so you can deliver on the important insight, analytics and solutions required to sense and react to threats and then drive action in order to make individuals healthier and safer.

BB: Executive leaders who are looking to browse this new world of healthcare, which was already relocating to value-based designs and currently had a huge requirement to combine otherwise siloed information into these common Precision Health Insight Networks. These executives have actually now been exposed to what its like to lead in the midst of a pandemic and also with an overlay of some strange political times that are leaving a great deal of people uneasy on where things are going. Those type of executives who are really taking note and wish to position their incorporated delivery network, health system and health insurance techniques for success not only in the coming year however really over the next 10 years, must attend this event.

Q: I understand that hc1 has a virtual Precision Health Summit prepared for November 17-18 with Beckers. Who should attend and what will they discover at the occasion?

Were going to be digging in and discussing particular examples and methods to deliver on precision health abilities in such a way thats very lucrative in this new era of value based care. Well also definitely discuss where the fee-for-service design fits into the formula due to the fact that youll never completely eliminate that. C-level executives and their key leaders who are tasked with producing these strategic strategies that permit them to at scale make individuals much healthier, while in parallel, substantially minimizing the expense of delivering care, this is the conference for you.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.